ENTITY

Tokai Pharmaceuticals (TKAI US)

Health Care • United States

Novus Therapeutics, Inc. operates as a pharmaceutical company. The Company provides acquisition, development, and commercialization of medicinal products for ear, nose, and throat disorders. Novus Therapeutics serves patients in the United States.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00